Blackpearl Group (NSX: BPG; proposed ASX: BPG) is set to join the ASX next Tuesday, 25 November following an oversubscribed $15 million raise and an additional $10.2 million placement completed this month, both receiving strong institutional support. The dual listing builds on strong recent momentum, with ARR rising to $19.5 million in Q2 FY26 and continued growth across its customer intelligence and data-driven marketing platforms. Its ASX debut is expected to support the Company’s expansion pipeline and drive the next phase of growth, as Blackpearl works towards achieving $50 million ARR.

Saluda Medical (proposed ASX: SLD) is preparing to make its ASX debut in early December in one of the year’s largest healthcare IPOs, raising ~$230 million to support the global rollout of its ECAP-controlled neuromodulation platform for chronic pain. The Company’s Evoke® system is already FDA-approved and generating accelerating revenue in the US, with Saluda targeting further penetration as it scales commercial operations. Covered by The Australian. 

TradeWindow Holdings (proposed ASX: TWL) is also set for a December ASX listing, raising $15 million to scale its digital trade platform used across supply chains in Australia, New Zealand and Asia. The Company’s software suite supports exporters, importers and logistics providers with compliant, end-to-end documentation workflows, with growth underpinned by increasing digitisation and regulatory demand for trusted data exchange.

Meanwhile, Atomic Eagle (ASX: AEU) is set to recommence ASX trading next week following the transformational merger of Tombador Iron (ASX: TI1) and GoviEx Uranium (TSX-V: GXU) to create a Zambian-focused uranium explorer, with ~$20m cash balance to advance exploration. 

Equus Energy (ASX: EQU) is also preparing for an imminent ASX listing, after acquiring the Equus Gas Project, a large-scale discovered and appraised gas resource on the North West Shelf, offshore of Karratha, WA. The Equus resource has been independently certified at 1.7 Tcf of gas and 38 mmbbls condensate.

Wagners (ASX: WGN) delivered a strong FY26 YTD trading update at its AGM, with rising cement, concrete and quarry volumes driving improved margins and record October concrete production. Its Composite Fibre Technologies division continues to outperform, with FY26 power pole sales expected to double FY25 on the back of strong demand and production efficiencies. Network expansion remains on track with new Slacks Creek and Wulkuraka concrete plants, while approvals progress at additional sites. The company issued upgraded guidance of $31–33m H1 EBIT and $52–56m FY26 EBIT, reflecting sustained momentum across the Group.

Commissioning is underway at Robex Resources’ (ASX: RXR) Kiniéro Gold Project in Guinea as it prepares for first gold this quarter. A commissioning and operations team is fully mobilised to site and first ore has been delivered to the ROM pad. Covered by Mining.com.au. The company also reported shallow, high-grade and wide gold results including 10m at 30.10g/t gold from 12m at Sabali South grade control drilling at Kiniero.

Acusensus (ASX: ACE) upgraded its FY26 revenue guidance at its AGM, now expecting $83–87 million versus the prior $79–84 million range, marking 40–46% growth on FY25. The uplift reflects a strong start to the year, supported by mobilisation of the New Zealand speed enforcement contract, the US$22.6m (~$34m) five-year Connecticut work zone enforcement win, and expansions across WA and Queensland programs. Management noted growing international momentum and continued uptake of its Forsite road-worker safety system as key contributors to the improved outlook.

Chimeric Therapeutics (ASX: CHM), Arovella Therapeutics (ASX: ALA) and Imugene (ASX: IMU) featured in coverage by Forbes Australia, with journalist Mark Whittaker taking a deep dive on local players in the CAR T sector in his piece, The Australian Biotechs Racing Toward the Next Billion Dollar Drug.

ReNerve (ASX: RNV) Managing Director and CEO Dr Julian Chick was interviewed by renowned markets commentator Alan Kohler for Intelligent Investor in ReNerve Regenerates.

AnteoTech’s (ASX: ADO) Ultranode™ X has surpassed 1,000 charge–discharge cycles at 80% capacity retention, meeting a key benchmark for EV and eVTOL batteries and marking a major milestone for its high-silicon anode technology. Using cost-effective, micron-sized pure silicon instead of expensive Si/C composites, Ultranode™ X offers scalable supply advantages, independent of trade restrictions. The breakthrough is believed to be an industry first for micron-silicon anodes and positions the company strongly for accelerating customer and partnership discussions across next-generation lithium-ion battery markets.

Wildcat Resources (ASX: WC8) expanded its Bolt Cutter Central lithium discovery to a 900m strike after new RC drilling confirmed significant extensions of the Harry pegmatite system. Results from 20 RC holes include 12m at 1.65% Li₂O from 90m (BCRC034), 11m at 1.32% Li₂O from 54m including 2m at 2.26% Li₂O (BCRC033), and 9m at 1.12% Li₂O from 33m (BCRC021), located 500m south of the original discovery. Mineralisation remains open in all directions, with continuous assays expected over the next three months as the 10,000m RC program progresses. Bolt Cutter Central sits ~10km west of Wildcat’s 74.1Mt Tabba Tabba Project. 

Argent Minerals (ASX: ARD) delivered record high-grade silver results at the Kempfield Silver-Polymetallic Project, with diamond drillhole AKDD210 returning 200.8m @ 140 g/t silver equivalent (Ag Eq.), including standout intervals of 99.8m @ 180.2 g/t Ag Eq. and 11.9m @ 491.7 g/t Ag Eq. Individual samples reporting up to 1,030 g/t silver, 3.80% Pb and 12.9% Zn. Covered by Stockhead.

Youtube | Spotify

Reeling in Growth: Inside Aquna’s Sustainable Murray Cod Story

In this episode of Vantage Point, we’re joined by Ross Anderson, CEO of Murray Cod Australia — the company behind Aquna Sustainable Murray Cod. From its base in the Riverina region of southern New South Wales, Murray Cod Australia has built a fully integrated aquaculture operation producing premium, sustainably farmed Murray cod for domestic and export markets. 

Ross shares how the company is scaling production to meet global demand, the innovation behind its farming systems and why Australia’s native Murray cod is making waves in the world of sustainable seafood.

Wildcat Resources (ASX: WC8) reaffirmed with a Speculative Buy rating by Canaccord Genuity, with a price target of $0.50 - more than 130% upside from the current share price of $0.21. The report highlights “a robust, capital-efficient, bottom-quartile cost development project with generous contingency” and points to optimisation opportunities including co-products (petalite/tantalum), mine plan refinement, and resource growth from regional targets. With $51M in cash, a granted mining lease, and DFS due in 2026, Wildcat is well-placed to fast-track Tabba Tabba toward production by 2028. 

MST Access has initiated coverage on Aurum Resources (ASX: AUE) with a valuation of A$1.25 per share, offering more than 130% upside from current levels. The report highlights Aurum’s rapid transformation into a well-funded West African gold developer with 3.3Moz in JORC Resources, a proven management team behind the Tietto success, and a fast-paced owner-operator drilling strategy delivering results. MST calls it “one of the most impressive gold project development strategies on the ASX,” with drilling, studies and approvals across Boundiali and Napie expected to significantly grow and de-risk the portfolio over the next 12 months.

Bell Potter and Euroz Hartleys initiated coverage on Frontier Energy (ASX: FHE). 

Bell Potter – $0.50/share target – "We initiate coverage with a BUY recommendation and a $0.50/ price target, seeing upside from: 1/ The company owns a strategically important site with approvals, access to the grid and land for later expansion. 2/ WA sees a structural shortage of energy supply at peak demand, as coal is retired. 3/ Average and peak prices have been rising. 4/ FHE has secured RCM credits worth $32m/yr, underpinning the project. 5/ There is considerable scope for more grid batteries to meet peak demand," analyst Marcus Barnard wrote. "Once operational, we expect that FHE’s Stage 1 project will generate $55m/yr of EBITDA from October 2027, with a long life of assets, low operating costs and a low cost of equity."

Euroz Hartleys – $0.39/share target – "We initiate coverage with a Speculative Buy recommendation, given the outstanding financing and development risks, and a Price Target of $0.39/sh based on a risked, blended, fully-diluted/fully-funded Sum-of-the-Parts valuation," analyst Declan Bonnick wrote. "Post-financing and construction, we see the potential for FHE to trade on an attractive EV/EBITDA multiple, in-line with ASX renewables focussed peers; i.e. 20x steady state EBITDA ($55m p.a.), underwriting the current valuation upside. Currently trading at ~8x fully diluted Stage 1 EBITDA (incl. debt). Stage 2 to double EBITDA (~$100m) potentially 1-2yrs behind."

RaaS released updated research commentary on Provaris Energy (ASX: PV1), highlighting NAV estimate of $0.10-0.17/share. “Provaris Energy represents a unique investment opportunity as a leveraged play on the growing shift globally to alternative energy and carbon reduction, but particularly in Europe. With the recommencement of hydrogen tank fabrication, commercial progress should accelerate from this point with testing and class certification of its proprietary tank design through Q1 2026. In parallel, the company is also progressing its CO2 business stream currently in the Front End Engineering Design (FEED) development phase and advancing at a more rapid pace than we had anticipated.”

METALS, MINING AND ENERGY

Trigg Minerals (ASX: TMG) consolidated the entire Tennessee Mountain Tungsten District in Nevada, securing the high-grade Little Joe and Gribble prospects and more than 75 historical workings. Historical US government data confirms high-grade tungsten (up to 0.85% WO₃ and mined grades of 0.9–1.5% WO₃), positioning the project as a district-scale critical minerals opportunity. With ~A$19m cash, Trigg is now advancing toward a maiden JORC resource and a potential U.S. national security–aligned tungsten supply. Covered by The Australian.

IRIS Metals (ASX: IR1) is pursuing a dual listing on a major US exchange, either Nasdaq or New York Stock Exchange (NYSE), as part of its strategic growth initiatives. This move underscores IRIS’ commitment to advancing as the key domestic supplier of critical minerals for the US, with mine permits already secured, a pipeline of brownfield developments and the largest exploration tenure in the Black Hills. Covered by Mining.com.au.

Auric Mining (ASX: AWJ) confirmed it will bank A$8.8 million (ex GST) in net revenue from the first three gold pours at the Munda Starter Pit - part of a total of $14.6 million in gold sales to date.   It produced 2,355 ounces of gold in three pours, highlighting the strong performance of the Munda operation. Covered by Australian Mining, Sydney Morning Herald and Mining.com.au.  The company also secured the acquisition of four tenements that form part of the Lindsay’s Gold Project at Gindalbie, 60km northeast of Kalgoorlie.

Larvotto Resources (ASX: LRV) reported strong drilling results at its Freehold prospect, confirming broad and high-grade antimony-gold mineralisation across multiple lodes and highlighting the resource growth potential at its Hillgrove Antimony-Gold Project. Hole FRE016 delivered 14m @ 4.25g/t AuEq from 89m including 2.6m @ 19.09g/t AuEq.  Diamond drilling program targeted extensions of historically mined stibnite-gold (Sb-Au) mineralisation. It also announced metallurgical testwork delivered 90% tungsten recovery and a 16-fold increase in concentrate grade, from the program assessing the viability of tungsten as a potential by-product stream. Covered by Australian Mining, BusinessNews, Mining.com.au and SMH.

Power Minerals (ASX: PNN) is advancing its Rincon Lithium Project JV, with final documentation now completed for the incorporation of the Rincon JV company and release of Navigate Energy’s US$4m investment. Once incorporated, funds will be released to progress development of a lithium brine pilot plant, supporting the 292,564t LCE Rincon Project, Power’s most advanced Salta asset, strategically located alongside Rio Tinto and Argosy. Covered by Stockhead.

Power also engaged Gega Elements to begin metallurgical testing of high-grade gallium samples from its Santa Anna Project in Brazil. Santa Anna has already returned multiple very high-grade gallium intersections, positioning the project as a potential new source of this strategically important critical mineral. Covered by Stockhead.

Magmatic Resources (ASX: MAG) has commenced drilling at its Myall FJVA Project with FMG Resources funding a $3.5 million work program designed to drill test multiple conceptual and advanced targets via 24-hole (~3000m) aircore and 14 diamond drill hole (~3000m) programs. The targets are prospective for Northparkes-style copper gold porphyry mineralisation. Covered by Stockhead.

Aurum Resources (ASX: AUE) delivered another standout intercept at its Boundiali Gold Project in Côte d’Ivoire, hitting 3.10m at 70.78 g/t gold within 5.10m at 43.13 g/t from 112.90m, outside the current 2.41Moz MRE. Multiple high-grade results confirm mineralisation remains open along strike and at depth as the Company accelerates its 100,000m drilling program with 12 rigs now active. Major resource updates for Boundiali and Napié are due in early Q1 2026, supported by a strong ~$45M cash position and a Boundiali PFS already underway. Covered by Business News.

Middle Island Resources’ (ASX:MDI) assay results from the first soil-sampling program conducted at the Tisovik target area within the Bobija Project, has outlined significant lead and zinc soil anomalies adjacent to the Tisovik Mining Lease, identifying multiple zones exceeding 400ppm Pb and 200ppm Zn.

FireFly Metals (ASX: FFM) announced a substantial Mineral Resource increase comprising strong growth in tonnes, grade and contained metal at its Green Bay Copper-Gold Project in Newfoundland, Canada. The Resource now stands at 50.4Mt @ 2.0% for 1Mt CuEq in the higher confidence M&I classifications plus an additional 29.3Mt @ 2.5% for 722kt CuEq in the Inferred category. This represents a 35% increase in tonnes and a 51% increase in CuEq metal from the Resource Estimate announced on 29 October 2024. Hear Managing Director Steve Parsons discuss with Proactive.

A Heritage survey is scheduled to start next week, covering an area of ~ 1.4sqkm at Bellavista Resources’ (ASX: BVR) Brumby Project. The survey will also include an area earmarked for resource drilling, which is planned for the 2026 field season. A comprehensive airborne LiDAR survey has been completed over the entire Edmund Basin Project portfolio, including Brumby. The results of the LiDAR survey, which will provide close, highly detailed imagery, are expected within weeks.

Strata Minerals (ASX: SMX) is gearing up to commence its maiden drilling program at the Zelica Gold Project in Western Australia by the end of November. The reverse circulation (RC) program will drill ~20 holes for 2,000m, targeting high-priority zones. Gold mineralisation extends ~1km and remains open along strike and at depth on a granted mining licence.

Aureka (ASX: AKA) delivered outstanding new results from its St Arnaud Comstock Project, including the highest-grade intercept ever recorded at the site — 0.3m @ 109g/t gold within a broader 1m @ 65.37g/t gold interval from shallow depths in hole 25NED002. Additional strong intercepts from holes 25NED003 and 25NED005 further extend mineralisation by up to 100 metres beyond the existing JORC Resource, reinforcing the scale and growth potential emerging within the Exploration Target.

Perpetual Resources (ASX: PEC) announced the identification of a new lithium-bearing pegmatite trend extending over 400 metres at its Mauricio Target (previously Southeast Anomaly), located in the Southeastern area of the Igrejinha tenement in Minas Gerais, Brazil. Covered in Stockhead.

Canadian Phosphate (AX: CP8) executed a non-binding letter of intent (LOI) with Novaphos Inc. to collaborate on potential development of new technology for phosphoric acid production in Canada. The partnership aims to utilise Novaphos’ proprietary phosphate processing

technology to help CP8 create more value from its existing rock phosphate projects

BIOTECH

Syntara (ASX: SNT) received a positive opinion from the European Medicines Agency for Orphan Drug Designation for amsulostat in myelofibrosis, adding to its existing US ODD status. The designation would provide significant EU development incentives, including ten years of market exclusivity upon approval. The news follows strong Phase 2a data, with 73% of patients achieving at least a 50% symptom reduction and nearly half showing spleen volume improvement, alongside excellent tolerability. Syntara is now advancing the design of the next clinical trial in consultation with regulators. Covered by AusBiotech 

Radiopharm Theranostics (ASX: RAD) announced that its Phase 2b trial evaluating RAD101 imaging in brain metasteses has achieved a 50% patient enrollment threshold. Data from the first three patients showed significant and selective tumor uptake in brain metastases. Images confirmed metabolic activity in brain metastases compared to equivocal MRI findings. These promising early results are in line with the previously published Phase 2a results and, if confirmed, will trigger the preparation of a multi-center, global Phase 3 registrational trial. Covered by Biotech Dispatch.

Radiopharm has also been granted Human Research Ethics Committee (HREC) approval in Australia to initiate its First-In-Human (FIH) Phase 1 clinical trial of the Company’s Kallikrein Related Peptidase 3 (KLK3)-targeting radiotherapeutic, RAD 402, for the treatment of metastatic or locally advanced prostate cancer. Covered by Small Caps.

BPH Global (ASX: BP8) released its sixth consecutive month of sales results from its Indonesian seaweed operations, delivering record gross sales of A$551,627 for the October Sales Period (15 Oct–14 Nov). This marks more than double its previous monthly record and reflects the strength of both its independent operations and its collaboration with PT Kebula Raya Bestari.

Emyria (ASX: EMD) has accelerated national expansion following institutional placement that exercises the option to establish Victorian Empax Clinic. Placement proceeds fast-track Emyria’s national expansion and reinforce defensible first - mover advantage, supported by a strengthened agreement with Avive Health, including exercising of the Mornington Option.

INDUSTRIALS

Bio-Gene’s (ASX: BGT) Qcide® has been approved by the Organic Materials Review Institute for listing as a Botanical Insecticide under the USDA National Organic Program, confirming it meets organic standards as a 100% natural, non-synthetic plant extract. The listing strengthens Qcide’s commercial positioning for future use in organic and sustainable pest-control markets and allows Bio-Gene to use the OMRI Listed® seal in product marketing. Once regulatory approvals are secured, Qcide can be used as an organic botanical insecticidal active across crop protection, consumer pest control and public health applications, supporting Bio-Gene’s strategy to develop natural, environmentally responsible insect control solutions. Covered by Small Caps.

LaserBond’s (ASX: LBL) CEO, Rob Freeman, provided a trading update during his address at the Company’s 2025 Annual General Meeting. Mr Freeman said LaserBond’s FY26 results to date reflect the strong momentum from the second half of FY25, with a robust order book extending into calendar 2026. The July to October period delivered revenues of $15.9 million and an NPBT (prior to the Company’s share of Gateway's profits) of $2.5 million.

TECHNOLOGY

Iondrive (ASX: ION) completed a Phase 1 Techno-Economic Evaluation confirming strong economics for its IONSolv™ modular REE recycling technology, including a post-tax NPV of US$7m, 46% IRR and a 2.6-year payback for a 2ktpa unit. The results support a scalable rollout across U.S. magnet-waste hubs and demonstrate meaningful value recovery from Nd, Pr and Dy-rich permanent magnets. Phase 2 laboratory validation is now underway to confirm process assumptions ahead of further engineering. Covered in SmallCaps.

CORPORATE NEWS

Radiopharm Theranostics (ASX: RAD) appointed Bruce Goodwin as a Non-Executive Director, who brings over four decades of experience across the global healthcare and biopharmaceutical industries. Bruce is a highly respected leader in the life sciences sector, currently serving as a Non-Executive Director across six organisations where he provides strategic guidance and governance expertise.

ReNerve (ASX: RNV) has received commitments from new and existing institutional and sophisticated investors, to raise approximately $3.2M before costs via a two-tranche placement. The Placement was well supported by new and existing shareholders.

EdenX Group (private), Melbourne-based fintech, has launched a US$5m funding round cornerstoned by Standard Chartered’s SC Ventures to accelerate capital markets infrastructure and franchise growth across Asia-Pacific. Covered by FinTechNews SG.

Blackpearl Group (NZX:BPG) HY FY26 Results Webinar TODAY at 10.15am AEDT - Register HERE

Decidr AI Industries Ltd (ASX: DAI) - Sugarwork Acquisition Investor Webinar TODAY at 11.15am AEDT - Register HERE

Inhalerx (ASX: IRX) hones in on pot for pain and panic in its quest for historic drug approval

Gladiator Metals (TSXV: GLAD) High-Grade Copper Discovery Positions Company for 2025 Growth

Iltani Resources’ (ASX: ILT) results from VTEM drilling featured in coverage by Australian Resources and Investment and Mining.com.au

Falcon Metals (ASX: FAL) and Magmatic Resources (ASX: MAG) are featured in this Australian Mining article on the growing investor interest in junior gold explorers

Noosa Mining Conference Presentation Replays

Argent Minerals (ASX: ARD) Advancing Silver, Gold & Copper Projects in Australia 

Rokeby Resources (ASX: RKB) High-Grade Gold & Antimony Exploration in Australia

Iltani Resources (ASX: ILT) Orient Silver Indium Project, Queensland

Kairos Minerals (ASX: KAI) Targeting Resource Growth through Accelerated Drilling at the 1.4Moz Mt York Gold Project, WA

Many Peaks Minerals (ASX:MPK) Managing Director Travis Schwertfeger chatted with Mining.com.au following the latest diamond drilling results from the Ferké Project, preliminary metallurgical testing showing 94% average gold recovery and upcoming exploration works as drill rigs mobilise onsite.

AnteoTech (ASX: ADO) Managing Director Merrill Gray spoke to Small Caps about its Ultranode X hitting 1,000 cycles at 80% capacity.  Ultranode X, AnteoTech’s high-silicon anode formulation, achieved over 1,000 full charge–discharge cycles with around 80% capacity retention, and why that milestone matters for EVs, drones and other high‑performance applications.

Tungsten Mining (ASX: TGN) held a webinar featuring Non-Executive Chair Gary Lyons, who outlined the updated Mt Mulgine Scoping Study results, the enhanced economic profile and the catalysts leading into the PFS.

Krakatoa Resources (ASX: KTA) CEO Mark Major spoke to Mining.com.au providing an update on exploration activity with Zopkhito with visual antimony identified from surface drilling and underground sampling.

Golden Dragon Mining (ASX: GDR) Managing Director Simon Buswell-Smith walked through the Cue Project’s drilling plans, its 2026 exploration outlook, and what’s shaping up to be a very active year ahead.

EQ Resources (ASX: EQR) Managing Director Craig Bradshaw and Chief Financial Officer Jono Kort delivered a concise operational and market update.